I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease

Peyrin-Biroulet Laurent, Rahier Jean-François, Kirchgesner Julien, Abitbol Vered, Sebastian Shaji, Armuzzi Alessandro, Karmiris Konstantinos, Gisbert Javier P., Bossuyt Peter, Helwig Ulf, Burisch Johan, Yanai Henit, Glen A. Doherty, Molnár Tamás, Kollaborációs Szervezet: I-CARE Collaborator Group
2023

Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease An ECCO CONFER Multicentre Case Series /

Festa Stefano, Zerboni Giulia, Derikx Lauranne A. A. P., Ribaldone Davide Giuseppe, Dragoni Gabriele, Buskens Christianne, Dijkum, van Els Nieveen, Pugliese Daniela, Panzuto Francesco, Krela-Kaźmierczak Iwona, Mintz Hilla Reiss, Shitrit Ariella Bar-Gil, Chaparro Marìa, Gisbert Javier P., Molnár Tamás
2022

Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn's Disease Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies /

Pauwels Renske W. M., van der Woude C. Janneke, Nieboer Daan, Steyerberg Ewout W., Casanova Maria J., Gisbert Javier P., Kennedy Nick A., Lees Charlie W., Louis Edouard, Molnár Tamás, Szántó Kata Judit, Leo Eduardo, Bots Steven, Downey Robert, Farkas Klaudia, Kollaborációs szervezet: CEASE Study Group
2022

Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

Garcia Maria Jose, Riestra Sabino, Amiot Aurelien, Julsgaard Mette, Garcia de la Filia Irene, Calafat Margalida, Aguas Mariam, de la Pena Luisa, Roig Cristina, Caballol Berta, Casanova Maria Jose, Farkas Klaudia, Boysen Trine, Bujanda Luis, Cuaran Camila, Dobru Daniela, Fousekis Fotios, Gargallo-Puyuelo Carla Jerusalen, Savarino Edoardo, Calvet Xavier, Huguet Jose Maria, Kupcinskas Limas, Lopez-Cardona Julia, Raine Tim, van Oostrom Joep, Gisbert Javier P., Chaparro Maria
2024